國家衛生研究院 NHRI:

Sub-Community

	于重元 [19/19]
	劉柯俊 [85/98]
	劉滄梧 [119/125]
	劉界元(2003-2010) [3/3]
	夏和雄(1996-2012) [26/31]
	夏興國 [51/54]
	姜乃榕 [82/94]
	常慧如 [39/44]
	張俊彥 [234/254]
	張光裕 [69/79]
	張憶壽 [103/106]
	張文祥 [52/53]
	張書銘 [89/91]
	彭汪嘉康(1996-2007) [120/126]
	施能耀 [37/43]
	李家惠 [29/29]
	李岳倫 [48/49]
	林素芳 [32/32]
	楊奕馨 [41/42]
	江士昇 [88/90]
	沈哲宏 [14/16]
	洪文俊 [88/88]
	莊雙恩 [82/91]
	蔡坤志 [32/34]
	蔡慧珍 [66/71]
	蘇勇曄 [40/40]
	蘇振良 [24/25]
	郭靜娟 [71/76]
	陳尚鴻 [45/48]
	陳振陽 [72/72]
	陳立宗 [443/510]
	陳美霞(2002-2009) [1/1]
	陳詩政 [2/2]
	陳雅雯 [38/39]
	黃智興 [55/55]
	黃道揚 [26/26]
	丁兆治(2000-2004) [5/5]
	其他 [464/471]
	劉敏(1996-2007) [60/62]
	劉玫英(2004-2006) [2/2]
	吳成文(1996-2008) [53/55]
	曾思文(1997-2007) [4/4]
	李冠德(1997-2004) [4/6]
	林景太(1999-2007) [5/5]
	楊文光(1996-1999) [21/21]
	王全正(1996-2003) [4/4]
	莊聲宏(1997-2004) [11/11]
	詹宗晃(2000-2008) [2/2]
	賴基銘(2004-2008) [41/47]
	阮麗蓉(2000-2006) [6/7]
	陳俊叡(2003-2007) [6/6]
	馬彥英(1997-1999) [1/1]
	黃奇英(2005-2007) [9/10]

Siblings

	分子與基因醫學研究所 [921/964]
	生技與藥物研究所 [830/1008]
	生醫工程與奈米醫學研究所 [1214/1334]
	免疫醫學研究中心 [224/236]
	神經及精神醫學研究中心 [782/804]
	細胞及系統醫學研究所 [755/815]
	感染症與疫苗研究所 [1541/1618]
	群體健康科學研究所 [2870/3000]
	國家環境醫學研究所 [1560/1591]
	國家蚊媒傳染病防治研究中心 [102/104]
	高齡醫學暨健康福祉研究中心 [216/224]
	論壇 [2/2]
	生醫資源中心 [7/7]
	研究生培育合作學程 [188/191]
	核心儀器設施中心 [9/9]
	病理核心實驗室 [14/14]
	實驗動物中心 [8/8]
	行政管理部門 [18/18]

Community Statistics

	近3年內發表的文件:335(13.91%)
	含全文筆數:2250(93.40%)
文件下載次數統計
	下載大於0次:2250(100.00%)
	下載大於100次:2250(100.00%)
	檔案下載總次數:1617686(30.18%)

最後更新時間: 2024-12-01 15:19

Top Upload

Top Download

Recent Submissions

	Pathological response following neo...
	Registry of genetic alterations of ...
	Activated single nucleotide mismatc...
	Taiwan nationwide study of first-li...
	The effectiveness of virtual passpo...
	Special Issue "Bioinformatics ...
	Evaluating a natural language proce...
	The clinicopathological significanc...
	Hypoxia in drug resistance and radi...
	DKK1 as a chemoresistant protein mo...

Jump to a point in the index:
Or type in a year:

Ordering With Most Recent First

Show Oldest First

Showing items 1451-1500 of 2409. (49 Page(s) Totally)
<< < 25 26 27 28 29 30 31 32 33 34 > >>
View [10|25|50] records per page

Date	Title	Relation
2013-05	Complete microscale profiling of tumor microangiogenesis: A microradiological methodology reveals fundamental aspects of tumor angiogenesis and yields an array of quantitative parameters for its characterization	Biotechnology Advances. 2013 May;31(3):396-401.
2013-05	Activation of PPAR-alpha induces cell cycle arrest and inhibits transforming growth factor-beta1 induction of smooth muscle cell phenotype in 10T1/2 mesenchymal cells	Cellular Signalling. 2013 May;25(5):1252-1263.
2013-05	Nutrient deprivation induces the Warburg effect through ROS/AMPK-dependent activation of pyruvate dehydrogenase kinase	Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 2013 May;1833(5):1147-1156.
2013-05	Mefloquine induces cell death in prostate cancer cells and provides a potential novel treatment strategy in vivo	Oncology Letters. 2013 May;5(5):1567-1571.
2013-05	Mefloquine exerts anticancer activity in prostate cancer cells via ROS-mediated modulation of Akt, ERK, JNK and AMPK signaling	Oncology Letters. 2013 May;5(5):1541-1545.
2013-05	Tumor burden talks in cancer treatment with PEGylated liposomal drugs	PLoS ONE. 2013 May;8(5):Article number e63078.
2013-05	Loss of epithelial membrane protein-2 expression confers an independent prognosticator in gallbladder carcinoma	Biomarkers and Genomic Medicine. 2013 May;5(1-2):31-38.
2013-05	E2F transcription factor 1 overexpression as a poor prognostic factor in patients with nasopharyngeal carcinomas	Biomarkers and Genomic Medicine. 2013 May;5(1-2):23-30.
2013-05	Concurrent chemoradiotherapy with cetuximab plus twice-weekly paclitaxel and cisplatin followed by esophagectomy for locally advanced esophageal squamous cell carcinoma	Journal of Clinical Oncology. 2013 May;31(15 Suppl.):Abstract number 10619.
2013-05	Effective treatment of aggressive B-cell lymphomas by downregulated NIK-induced noncanonical NF-kappa B pathway activation through inhibition of BAFF	Journal of Clinical Oncology. 2013 May;31(15 Suppl.):Abstract number e13554.
2013-05	KRAS mutation status-stratified randomized phase II trial of GEMOX with and without cetuximab in advanced biliary tract cancer (ABTC): The TCOG T1210 trial	Journal of Clinical Oncology. 2013 May;31(15 Suppl.):Abstract number 4018.
2013-05	Impact of virologic factors on recurrence-free survival in HBV-related hepatocellular carcinoma after surgical resection: Post hoc analysis from a prospective study with long-term follow-up	Journal of Clinical Oncology. 2013 May;31(15 Suppl.):Abstract number e15032.
2013-04-24	Caffeic acid phenethyl ester suppresses proliferation and survival of TW2.6 human oral cancer cells via inhibition of Akt signaling	International Journal of Molecular Sciences. 2013 Apr 24;14(5):8801-8817.
2013-04-22	The epidemiology of neuroendocrine tumors in Taiwan: A nation-wide cancer registry-based study	PLoS ONE. 2013 Apr 22;8(4):Article number e62487.
2013-04	Fatty acid synthase overexpression confers an independent prognosticator and associates with radiation resistance in nasopharyngeal carcinoma	Tumor Biology. 2013 Apr;34(2):759-768.
2013-04	Up-regulation of miR-182 by Beta-catenin in breast cancer increases tumorigenicity and invasiveness by targeting the matrix metalloproteinase inhibitor RECK	Biochimica et Biophysica Acta (BBA)-General Subjects. 2013 Apr;1830(4):3067-3076.
2013-04	SKP2 overexpression is associated with a poor prognosis of rectal cancer treated with chemoradiotherapy and represents a therapeutic target with high potential	Tumor Biology. 2013 Apr;34(2):1107-1117.
2013-04	Functional implication of TGFBR3 dysregulation and its clinical application in oral cancer	Cancer Research. 2013 Apr;73(8 Suppl. 1):Abstract number 3987.
2013-04	Generation and characterization of highly selective cathepsin S inhibitors with potentials against pancreatic cancer	Cancer Research. 2013 Apr;73(8 Suppl. 1):Abstract number 5562.
2013-04	3-D imaging and illustration of nerve-lesion association in the mouse tongue of experimental oral cancer	Cancer Research. 2013 Apr;73(8 Suppl. 1):Abstract number 716
2013-04	EGFR variant III act as the major determinant factors in the EGFR/PI3K/AKT pathway for the survival outcome of oral cancer patients	Cancer Research. 2013 Apr;73(8 Suppl. 1):Abstract number 2390.
2013-04	Autophagy induced by cathepsin S inhibition causes early ROS production for oxidative DNA damage and subsequent cell death	Cancer Research. 2013 Apr;73(8 Suppl. 1):Abstract number 1661.
2013-04	Serum retinol and risk of head and neck cancer	Cancer Research. 2013 Apr;73(8):Abstract number 105.
2013-03-29	Secreted heat shock protein 90alpha (HSP90alpha) induces nuclear factor-kappaB-mediated TCF12 protein expression to down-regulate E-cadherin and to enhance colorectal cancer cell migration and invasion	Journal of Biological Chemistry. 2013 Mar 29;288(13):9001-9010.
2013-03-15	Analgesic and anti-inflammatory bioactivities of eburicoic acid and dehydroeburicoic acid isolated from antrodia camphorata on the inflammatory mediator expression in mice	Journal of Agricultural and Food Chemistry. 2013 Mar 15;61(21):5064-5071.
2013-03-12	A novel synthetic microtubule inhibitor, MPT0B214 exhibits antitumor activity in human tumor cells through mitochondria-dependent intrinsic pathway	PLoS ONE. 2013 Mar 12;8(3):Article number e58953.
2013-03-06	Caffeic acid phenethyl ester as a potential treatment for advanced prostate cancer targeting akt signaling	International Journal of Molecular Sciences. 2013 Mar 6;14(3):5264-5283.
2013-03	Copy-number variations in hepatoblastoma associate with unique clinical features	Hepatology International. 2013 Mar;7(1):208-214.
2013-03	Characterization of ELISA detection of broad-spectrum anti-Epstein–Barr virus antibodies associated with nasopharyngeal carcinoma	Journal of Medical Virology. 2013 Mar;85(3):524-529.
2013-03	Inhibition of lymphangiogenic factor VEGF-C expression and production by the histone deacetylase inhibitor suberoylanilide hydroxamic acid in breast cancer cells	Oncology Reports. 2013 Mar;29(3):1238-1244.
2013-03	Uropathogenic Escherichia coli causes cortical tubular necrotic cell death and the release of macrophage migration inhibitory factor	Cytokine. 2013 Mar;61(3):945-952.
2013-03	The homeobox transcription factor Prox1 inhibits proliferation of hepatocellular carcinoma cells by inducing p53-dependent senescence-like phenotype	Cancer Biology and Therapy. 2013 Mar;14(3):222-229.
2013-03	Ethanol extracts of fruiting bodies of antrodia cinnamomea suppress CL1-5 human lung adenocarcinoma cells migration by inhibiting matrix metalloproteinase-2/9 through ERK, JNK, p38, and PI3K/Akt signaling pathways [Erratum: Evidence-based Complementary and Alternative Medicine. 2013; 2013:Article ID 378415]	Evidence-based Complementary and Alternative Medicine. 2013 Mar;2013:Article ID 423987.
2013-03	Auy922, a novel Hsp90 inhibitor effective against ABC-dlbcl and malt lymphoma cells harboring genetic alteration-associated NF-kappa B activation	Annals of Oncology. 2013 Mar;24(Suppl. 1):24-25.
2013-03	Targeting to tumor-associated antigen eno1 provides preventive and therapeutic effects on disease progression of lung cancer	Annals of Oncology. 2013 Mar;24(Suppl. 1):27.
2013-03	Honokiol eliminates human oral cancer stem-like cells accompanied with suppression of Wnt/beta-catenin signaling and apoptosis induction	Evidence-based Complementary and Alternative Medicine. 2013 Mar;2013:Article number 146136.
2013-02-01	Allergies and risk of head and neck cancer: An original study plus meta-analysis	PLoS ONE. 2013 Feb 1;8(2):Article number e55138.
2013-02	Targeted endostatin-cytosine deaminase fusion gene therapy plus 5-fluorocytosine suppresses ovarian tumor growth	Oncogene. 2013 Feb;32(9):1082-1090.
2013-02	Cyclooxygenase-2 up-regulates CCR7 expression via AKT-mediated phosphorylation and activation of Sp1 in breast cancer cells	Journal of Cellular Physiology. 2013 Feb;228(2):341-348.
2013-02	Autophagy is involved in endogenous and NVP-AUY922-induced KIT degradation in gastrointestinal stromal tumors	Autophagy. 2013 Feb;9(2):220-233.
2013-02	Krüppel-like factor 10 upregulates the expression of cyclooxygenase 1 and further modulates angiogenesis in endothelial cell and platelet aggregation in gene-deficient mice	International Journal of Biochemistry and Cell Biology. 2013 Feb;45(2):419-428.
2013-02	Molecular profiling of prostatic acinar morphogenesis identifies PDCD4 and KLF6 as tissue architecture-specific prognostic markers in prostate cancer	American Journal of Pathology. 2013 Feb;182(2):363-374.
2013-02	GFBP5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder	Modern Pathology. 2013 Feb;26(Suppl. 2):230A.
2013-02	Periostin overexpression as a poor prognostic factor in patients with nasopharyngeal carcinoma	Modern Pathology. 2013 Feb;26(Suppl. 2):308A.
2013-02	TOP2A overexpression as a poor prognostic factor in patients with nasopharyngeal carcinoma	Modern Pathology. 2013 Feb;26(Suppl. 2):308A.
2013-02	Angiomatoid fibrous histiocytoma: Clincopathological and molecular characterization with emphasis on variant histomorphology	Laboratory Investigation. 2013 Feb;93(Suppl. 1):14A.
2013-02	TOP2A overexpression as a poor prognostic factor in patients with nasopharyngeal carcinoma	Laboratory Investigation. 2013 Feb;93(Suppl. 1):308A.
2013-02	GFBP5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder	Laboratory Investigation. 2013 Feb;93(Suppl. 1):230A.
2013-02	Angiomatoid fibrous histiocytoma: Clincopathological and molecular characterization with emphasis on variant histomorphology	Modern Pathology. 2013 Feb;26(Suppl. 2):14A.
2013-02	Periostin overexpression as a poor prognostic factor in patients with nasopharyngeal carcinoma	Laboratory Investigation. 2013 Feb;93(Suppl. 1):308A.